PharmaStart Implements Veeva's Vault eTMF - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
PharmaStart Implements Veeva's Vault eTMF

Source: Applied Clinical Trials

PharmaStart, a CRO with offices in Illinois, Ohio, North Carolina, California and London, has implemented Veeva System's Valut eTMF solution.

Users of PharmaStart's new solution include its internal teams, clinical partners, and its 75+ investigator sites around the globe. The CRO chose a cloud-based solution for real-time access, improved productivity, as well as a reduction in paper. The Vault eTMF allows PharmStart's processes and workflows to be automated so individual sites pull down a template, complete it, and upload it back into Vault for stakeholder visibility in real time. In addition, placement into the eTMF happens automatically. The company maintains it has addressed hidden cost savings as TMF documents are uploaded, QC’d, and approved in the system along the way. For study start-up, there is less need for managing documents and signatures, and at study close-out eliminates the document reconciliation process.

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here